Melbourne, Australia and Seoul, South Korea
28 June 2021
Cartherics Pty Ltd (“Cartherics”) and ToolGen, Inc. (“ToolGen”) announced today that they have entered into a commercial licence agreement.
Under the agreement, Cartherics obtains […]
By Leigh Dayton
14 June 2021
From his early days in cattle IVF, then human IVF – as part of Australia’s first IVF team with Monash University’s Carl Wood – to his advances in embryonic stem cell research […]
By Leigh Dayton
11 June 2021
Alan Trounson joined a day-long discussion on advances in regenerative medicine. The virtual event brought together the world’s leading experts.
At the session on emerging immuno-oncology, Trounson told delegates that Cartherics believes its novel CAR-T and CAR-NK cells have great potential […]
By Hayden Smith, 7 June 2021
‘It was mid-March at Fiona Stanley Hospital in Perth, and a squadron of doctors and nurses had gathered by my bed. Some were methodically […]
By Heather Hawkins
24 May 2021
Even today – and it’s been 14 years since diagnosis – they still evoke a very raw and deeply emotional response. It was the first time I’d faced the undeniable fact […]
Four Australian women are diagnosed with ovarian cancer a day and three will eventually die from the disease. It’s usually diagnosed late, because few women show symptoms until they have advanced cancer.
As a junior doctor in London in the mid-1980s, Ian Jacobs saw women undergo chemo and […]
The COVID pandemic has made it another difficult year for many. But it is important to keep in mind that in Australia one woman loses her battle with ovarian cancer every eight hours. That is why Cartherics supports World Ovarian Cancer Day and the 170 organisations which promote it worldwide.
On 8 May members of the […]
The first in a provocative series on the complexities of advanced therapeutic approaches to cancer
By Jeff Brockman and Joel Sandler of Cello Health BioConsulting
“In 1890, the Russian playwright and physician Anton Chekov (pictured above) wrote a letter in which he alluded to a centuries-old observation that infections seemed to slow the growth of […]
11 March 2021
Cartherics is pleased to announce that on 8 March 2021 a review paper was approved for production and accepted for publication in the journal Frontiers in Genetics, section Cancer Genetics.
Titled: A role for integrin-linked kinase in colorectal cancer growth and progression via regulating senescence and immunity, the paper is a collaboration between Cartherics, […]
Melbourne, Australia, 04 March 2021.
Cartherics Pty Ltd announced today the grant of a European patent entitled “Genetically modified cells and uses thereof”. The patent covers aspects of Cartherics’ chimeric antigen receptor (CAR) technology, particularly in relation to its CAR directed against the tumour-associated antigen, TAG-72.
This patent is […]
Cartherics’ mission is the development of novel, immune cell therapy products for the treatment of cancer, endometriosis and Alzheimer’s disease.
Stay informed about our latest news and developments
© Copyright 2022 | Cartherics Pty ltd
